Related Experiment Video

Updated: May 31, 2025

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.1K

Osmotic stress influences microtubule drug response via WNK1 kinase signaling

Ana Monfort-Vengut1, Natalia Sanz-Gómez2, Sandra Ballesteros-Sánchez2

  • 1Cell Cycle & Cancer Biomarkers Laboratory, Cancer Department, Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) CSIC-UAM, Madrid 28029, Spain.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|January 24, 2025
PubMed

Insights

WNK1 kinase regulates cellular response to cancer drugs targeting microtubules. Its osmoregulation activity impacts chemotherapy effectiveness, offering new strategies for cancer treatment.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Ion homeostasis is crucial for cellular functions and implicated in cancer progression.
  • Targeting ion balance is a potential cancer treatment strategy.
  • The influence of ion homeostasis on anticancer drug response remains largely unexplored.

Purpose of the Study:

  • To identify regulators of anticancer drug response.
  • To investigate the role of ion homeostasis in modulating chemotherapy effectiveness.
  • To explore the WNK1 kinase's function in cancer treatment response.

Main Methods:

  • Genome-wide CRISPR-Cas9 resistance drug screening.
  • Validation of WNK1 kinase as a modulator of rigosertib response.
  • Analysis of cellular response to microtubule-targeting drugs under osmotic stress and WNK1 inactivation.

Main Results:

  • WNK1 kinase identified as a key regulator of response to rigosertib, a mitotic inhibitor.
  • Osmotic stress and WNK1 inactivation alter cellular response to microtubule-related drugs.
  • Reduced mitotic arrest observed with WNK1 inactivation, impacting microtubule stability and polymerization.

Conclusions:

  • WNK1 kinase osmoregulation activity modulates response to microtubule-associated chemotherapy.
  • WNK1 inactivation confers resistance to microtubule depolymerizing agents and sensitivity to stabilizing agents.
  • Findings suggest WNK1 as a potential therapeutic target for optimizing cancer chemotherapy.
Keywords:
Microtubule dynamicsMitosisOsmotic stressRigosertibWNK1

More Related Videos

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis05:47

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis

Published on: June 25, 2020

5.1K
Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis08:08

Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis

Published on: February 19, 2018

8.5K

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
1.7K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K